Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb 8;17(2):e0263794.
doi: 10.1371/journal.pone.0263794. eCollection 2022.

Sequencing SARS-CoV-2 from antigen tests

Affiliations

Sequencing SARS-CoV-2 from antigen tests

Ashley Nazario-Toole et al. PLoS One. .

Abstract

Genomic surveillance empowers agile responses to SARS-CoV-2 by enabling scientists and public health analysts to issue recommendations aimed at slowing transmission, prioritizing contact tracing, and building a robust genomic sequencing surveillance strategy. Since the start of the pandemic, real time RT-PCR diagnostic testing from upper respiratory specimens, such as nasopharyngeal (NP) swabs, has been the standard. Moreover, respiratory samples in viral transport media are the ideal specimen for SARS-CoV-2 whole-genome sequencing (WGS). In early 2021, many clinicians transitioned to antigen-based SARS-CoV-2 detection tests, which use anterior nasal swabs for SARS-CoV-2 antigen detection. Despite this shift in testing methods, the need for whole-genome sequence surveillance remains. Thus, we developed a workflow for whole-genome sequencing with antigen test-derived swabs as an input rather than nasopharyngeal swabs. In this study, we use excess clinical specimens processed using the BinaxNOW™ COVID-19 Ag Card. We demonstrate that whole-genome sequencing from antigen tests is feasible and yields similar results from RT-PCR-based assays utilizing a swab in viral transport media.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Assay development.
(A) An NP specimen was used to evaluate the feasibility of obtaining viral RNA from Ag-card derived specimens. RT-PCR was carried out on a positive control and on mock Ag-card specimens collected under each condition. (B) RT-PCR N1 and RP Ct values, sequence library quality scores, and viral PANGO lineage assignments of antigen card specimens and reference NP specimen #5195. (C) IGV screen shots of sample SARS-CoV-2 genome coverage. VR-1986D = Positive Control Genomic RNA from SARS-Cov-2, Isolate USA-WA1/2020.
Fig 2
Fig 2. Sample source performance comparison.
(A) SARS-CoV-2 positive BinaxNOW™ COVID-19 Ag Cards were used to evaluate which part of the card, swab or lateral flow positive line, yielded the highest quantity and quality of viral RNA. Extracted RNA was tested for N1 and RP levels using RT-PCR. The average N1 and RP CT values are plotted. n = 7 cards. Statistical analysis = Two-tailed, paired t-test, * p<0.05; *** p<0.0005 (B) N1 and RP Ct values, library quality scores and PANGO lineage assignments. (C) IGV screen shots of SARS-CoV-2 genome coverage.

Similar articles

Cited by

References

    1. Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20: 533–534. doi: 10.1016/S1473-3099(20)30120-1 - DOI - PMC - PubMed
    1. Long SW, Olsen RJ, Christensen PA, Subedi S, Olson R, Davis JJ, et al.. Sequence Analysis of 20,453 Severe Acute Respiratory Syndrome Coronavirus 2 Genomes from the Houston Metropolitan Area Identifies the Emergence and Widespread Distribution of Multiple Isolates of All Major Variants of Concern. Am J Pathol. 2021;191: 983–992. doi: 10.1016/j.ajpath.2021.03.004 - DOI - PMC - PubMed
    1. Cyranoski D. Alarming COVID variants show vital role of genomic surveillance. Nature. 2021;589: 337–338. doi: 10.1038/d41586-021-00065-4 - DOI - PubMed
    1. Li X, Wang W, Zhao X, Zai J, Zhao Q, Li Y, et al.. Transmission dynamics and evolutionary history of 2019-nCoV. J Med Virol. 2020;92: 501–511. doi: 10.1002/jmv.25701 - DOI - PMC - PubMed
    1. Tillett RL, Sevinsky JR, Hartley PD, Kerwin H, Crawford N, Gorzalski A, et al.. Genomic evidence for reinfection with SARS-CoV-2: a case study. Lancet Infect Dis. 2021;21: 52–58. doi: 10.1016/S1473-3099(20)30764-7 - DOI - PMC - PubMed

Publication types

MeSH terms